Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ENV3 | ISIN: US09075F3055 | Ticker-Symbol: 2Y30
NASDAQ
19.04.24
21:59 Uhr
0,756 US-Dollar
-0,032
-4,03 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIONANO GENOMICS INC Chart 1 Jahr
5-Tage-Chart
BIONANO GENOMICS INC 5-Tage-Chart

Aktuelle News zur BIONANO GENOMICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.04.Bionano Genomics: Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing124SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping...
► Artikel lesen
05.04.Bionano Genomics, Inc. - 8-K, Current Report9
04.04.Bionano announces $10M registered direct offering11
04.04.Bionano Genomics: Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules7
03.04.Bionano Genomics: Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics4
07.03.Bionano Genomics: Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys System25
06.03.Earnings call: Bionano reports solid growth and strategic shifts for 202416
06.03.Bionano Genomics stock price target cut to $3 amid restructuring11
05.03.Bionano Genomics, Inc. - 10-K, Annual Report3
05.03.Bionano Genomics: Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024169Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase over FY 2022Reached installed base of 326 optical...
► Artikel lesen
04.03.Earnings Outlook For Bionano Genomics9
29.02.Bionano Genomics: Bionano to Present at TD Cowen's 44th Annual Health Care Conference4
28.02.Bionano Genomics, Inc. - 8-K, Current Report3
28.02.Bionano Genomics: Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway5
28.02.Bionano Genomics: Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 20242
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 34.097The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS00941Q2030 AIRNET...
► Artikel lesen
31.01.Bionano Genomics: Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference15
26.01.How Is The Market Feeling About Bionano Genomics?15
24.01.Bionano Genomics: Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing398Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that is designed to measure the workflow's accuracy and...
► Artikel lesen
19.01.Bionano Genomics: Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications7
Seite:  Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,3